tiprankstipranks
Pfizer (DE:PFE)
XETRA:PFE
Holding DE:PFE?
Track your performance easily

Pfizer (PFE) Technical Analysis

158 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pfizer’s (PFE) Moving Averages Convergence Divergence (MACD) indicator is -0.56, suggesting Pfizer is a Buy.
Pfizer’s (PFE) 20-Day exponential moving average is 24.95, while Pfizer’s (PFE) share price is €23.55, making it a Sell.
Pfizer’s (PFE) 50-Day exponential moving average is 25.49, while Pfizer’s (PFE) share price is €23.55, making it a Sell.

Pfizer (PFE) Pivot Points

Nov 22, 2024, 12:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.03
23.27
23.38
23.62
23.73
23.97
24.08
Fibonacci
23.27
23.40
23.48
23.62
23.75
23.83
23.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pfizer (PFE) Moving Averages

Nov 22, 2024, 12:27 AM
Period
Simple
Exponential
MA5
24.16Sell
24.02Sell
MA10
24.54Sell
24.44Sell
MA20
25.18Sell
24.95Sell
MA50
25.76Sell
25.49Sell
MA100
25.90Sell
25.60Sell
MA200
25.22Sell
25.26Sell
Pfizer’s (PFE) 10-Day exponential moving average is 24.44, while Pfizer’s (PFE) share price is €23.55, making it a Sell.
Pfizer’s (PFE) 100-Day exponential moving average is 25.60, while Pfizer’s (PFE) share price is €23.55, making it a Sell.
Pfizer’s (PFE) stock price is €23.55 and Pfizer’s (PFE) 50-day simple moving average is 25.76, creating a Sell signal.
Pfizer’s (PFE) stock price is €23.55 and Pfizer’s (PFE) 100-day simple moving average is 25.90, creating a Sell signal.
Pfizer’s (PFE) stock price is €23.55 and Pfizer’s (PFE) 200-day simple moving average is 25.22, creating a Sell signal.

Pfizer (PFE) Technical Indicators

Nov 22, 2024, 12:27 AM
Name
Value
Implied Action
RSI (14)
31.10
Neutral
STOCH (9,6)
11.64
Buy
STOCHRSI (14)
9.08
Buy
MACD (12,26)
-0.56
Buy
ADX (14)
20.84
Neutral
Williams %R
-85.08
Buy
CCI (14)
-160.28
Buy
ATR (14)
0.67
-
Ultimate Oscillator
23.30
Sell
ROC
-7.49
Sell
Pfizer’s (PFE) Relative Strength Index (RSI) is 31.10, creating a Neutral signal.
Pfizer’s (PFE) Trend Strength Indicator (ADX) is 20.84, creating a Neutral signal.
Pfizer’s (PFE) Commodity Channel Index (CCI) is -160.28, creating a Buy signal.
Pfizer’s (PFE) Price Rate of Change (ROC) is -7.49, creating a Sell signal.

FAQ

Is PFE a Buy, Hold, or Sell?
Based on PFE’s technical indicators, PFE is a Sell.
    What is PFE’s RSI (14)?
    PFE’s RSI (14) is 31.10, which suggests PFE is a Neutral.
      What is PFE’s MACD?
      PFE’s MACD is -0.56, which suggests PFE is a Buy.
        What is PFE’s 5-day moving average?
        PFE’s 5-day moving average is 24.16, which suggests PFE is a Sell.
          What is PFE’s 20-day moving average?
          PFE 20-day moving average is 25.18, which suggests PFE is a Sell.
            What is PFE’s 50-day moving average?
            PFE’s 50-day moving average is 25.76, which suggests PFE is a Sell.
              What is PFE’s 200-day moving average?
              PFE’s 200-day moving average is 25.22, which suggests PFE is a Sell.
                What is PFE’s Williams % R (14)?
                PFE’s Williams % R (14) is -85.08, which suggests PFE is a Buy.
                  What is PFE’s CCI (14)?
                  PFE’s CCI (14) is -160.28, which suggests PFE is a Buy.
                    What is the share price of Pfizer?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis